| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVS | Common Stock | Award | $0 | +16.8K | +82.49% | $0.00 | 37.2K | Feb 12, 2024 | Direct | F1 |
| holding | CVS | Common Stock (Restricted) | 14.7K | Feb 12, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CVS | Stock Option | 27.6K | Feb 12, 2024 | Common Stock | 27.6K | $74.30 | Direct | F2 | |||||
| holding | CVS | Stock Option | 21.8K | Feb 12, 2024 | Common Stock | 21.8K | $101.09 | Direct | F3 | |||||
| holding | CVS | Stock Option | 52K | Feb 12, 2024 | Common Stock | 52K | $74.31 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. |
| F2 | Option became exercisable in four equal installments, commencing 4/1/2022. |
| F3 | Option became exercisable in four equal installments, commencing 4/1/2023. |
| F4 | Option becomes exercisable in four equal installments, commencing 4/1/2024. |